REDESIGNING THE ROLES OF TUBERCULOSIS TREATMENT SUPPORTER IN INDONESIA
Downloads
Background: Indonesia is the third-highest rank country for tuberculosis. Many studies already compared the effectiveness of the Directly Observed Treatment-Short (DOTS) course with self-administered therapy (SAT) in tuberculosis treatment and pointed out that DOTS did not improve the succession rate (SR) significantly. The participation of a tuberculosis treatment supporter that has an important rule in the DOTS strategy to improve the patients' adherence in taking treatment should be reviewed.
Aims: The study aims to analyze the determination of environmental factors in the effectiveness of tuberculosis treatment which can lead to the program improvement issue.
Method: This research was a cross-sectional study conducted by involving 55 of 121 tuberculosis patients. The sampling frame was tuberculosis patients who were reported under the first and third quarters in Primary Healthcare Center ofTanah Kalikedinding as it had failed to reach the succession rate during 2012-2015.
Results: These findings indicated that the social environment of tuberculosis patients significantly contributed to their adherence to taking medicine. It showed that tuberculosis treatment supporters had an essential role in maintaining the patients' adherence. Tuberculosis treatment supporters who lived in one roof with the patient tended to get 2.265 times risk to be contagious. This study also pointed out that the physical environment had the highest determination in the success rate of treatment.
Conclusion: Modifying the physical environment of tuberculosis patients can be the greater alternative program to fight tuberculosis rather than the tuberculosis treatment supporters. Tuberculosis treatment supporters must be provided with universal protection due to their high-risk position to be contagious.
Keywords: treatment adherence, DOTS,patientenvironment, treatment effectiveness.
Beyanga, M. et al. (2018) ‘Investigation of Household Contacts of Pulmonary Tuberculosis Patients Increases Case Detection in Mwanza City , Tanzania', BMC Infectious Disease. BMC Infectious Diseases, 18(110), pp. 1–8. doi: 10.1186/s12879-018-3036-6.
Coíªlho, A. A. et al. (2017) ‘A Meta-Analysis of Directly Observed Treatment vs . Self- Ad- ministered Therapy Outcomes in Pulmonary Tuberculosis Patients', Journal of Infectious Diseases and Epidemiology, 3(1), pp. 1–7. doi: 10.23937/2474-3658/1510027.
Crum, A. and Zuckerman, B. (2017) ‘Changing Mindsets to Enhance Treatment TEMPEffectiveness', JAMA, 317(20), pp. 2063–2064. doi: 10.1001/jama.2017.4545.
Deun, A. Van and Rieder, H. L. (2012) ‘DOT , S , or DOTS ?', Public Health Action, 2(1), pp. 3–4. doi: 10.5588/pha.12.0007.
Hussain, S. et al. (2018) ‘Type of Treatment Supporters in Successful Completion of Tuberculosis Treatment: A Retrospective Cohort Study in Pakistan', Teh Open Infectious Diseases Journal, 10, pp. 37–42. doi: 10.2174/1874279301810010037.Type.
Irnawati, N. M., Siagian, I. E. T. and Ottay, R. I. (2016) ‘Pengaruh Dukungan Keluarga Terhadap Kepatuhan Minum Obat Pada Penderita Tuberkulosis di Puskesmas Motoboi Kecil Kota Kotamobagu', Jurnal Kedokteran Komunitas dan Tropik, 4(1).
Jose, J. et al. (2019) ‘Medication Adherence To Anti Tuberculosis Treatment Among Tuberculosis Patients In An Urban Private Tertiary Referral Hospital: A Prospective Cross Sectional Study', World Journal of Pharmaceutical Research, 8(6), pp. 598–612. doi: 10.20959/wjpr20196-14750.
Karumbi, J. and Garner, P. (2015) ‘Directly Observed Therapy for Treating Tuberculosis', Cochrane Database of Systematic Reviews. Art: John Wiley & Sons, Ltd, (5). doi: 10.1002/14651858.CD003343.pub4.
Lupitayanti, L. E. and Putra, I. W. G. A. E. (2014) ‘Kinerja Pengawas Menelan Obat (PMO) Penderita TB Paru BTA+ Di Puskesmas I Denpasar Selatan Tahun 2012', Community Health, 2(1), pp. 141–147.
Madhona, R., Ikhwan, Z. and Aminin, F. (2017) ‘Physical Environment Home and Incidence of TB Disease in Tanjungpinang District', in Advances in Health Sciences Research. Atlantis Press. doi: 10.2991/phico-16.2017.77.
Ministry of Health of Republic Indonesia (2010) Pengendalian TB di Indonesia Mendekati MDGs. Jakarta. Available at: http://www.depkes.go.id/article/print/857/pengendalian-tb-di-indonesia-mendekati-target-mdg.html.
Ministry of Health of Republic Indonesia (2011) Pedoman Nasional Pengendalian Tuberkulosis. Jakarta: Kementerian Kesehatan Republik Indonesia Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan.
Ministry of Health of Republic Indonesia (2018) ‘Tuberkulosis', Infodatin, p. 4. Available at: http://www.depkes.go.id/download.php?file=download/pusdatin/infodatin/infodatin tuberkulosis 2018.pdf.
Out, A. A. (2013) ‘Is Teh Directly Observed Therapy Short Course ( DOTS ) an TEMPEffective Strategy for Tuberculosis Control in a Developing Country ?', Asian Pacific Journal of Tropical Disease, 3(3), pp. 227–231. doi: 10.1016/S2222-1808(13)60045-6.
Parida, A. et al. (2014) ‘Comparison of Directly Observed Treatment Short Course ( DOTS ) wif Self-Administered Therapy in Pulmonary Tuberculosis in Udupi District of Southern India', Journal of Clinical and Diagnostic Research, 8(8), pp. 29–31. doi: 10.7860/JCDR/2014/8865.4721.
Prameswari, A. (2018) ‘Teh Evaluation of Directly Observed Treatment Short-Course ( DOTS ) Implementation for TB in Hospital X', Jurnal Medicoeticolegal dan Manajemen Rumah Sakit, 7(2), pp. 93–101. doi: 10.18196/jmmr.7261.
Prihantoro, A. (2013) Hubungan Tingkat Pengetahuan Pengawas Minum Obat (PMO) Penderita TBC dengan Perilaku Pencegahan Penularan TBC di Wilayah Kerja Puskesmas Jatiyoso Kabupaten Karanganyar. Undergraduate Thesis. University of Muhammadiyah Surakarta.
Srivastava, K., Kant, S. and Verma, A. (2015) ‘Role of Environmental factors in Transmission of Tuberculosis', Dynamics of Human Health, 2(4).
Tian, J. et al. (2014) ‘TEMPEffectiveness of Directly Observed Treatment of Tuberculosis : A Systematic Review of Controlled Studies TEMPEffectiveness of Directly Observed Treatment of Tuberculosis : A Systematic Review of Controlled Studies', International Journal of Tuberculosis and Lung Disease, 18(9). doi: 10.5588/ijtld.13.0867.
World Health Organization (1999) What is DOTS ? A Guide to Understanding teh WHO-recommended TB Control Strategy Known as DOTS. 1st edn. Geneva: World Health Organization.
World Health Organization (2006) Teh Stop TB Strategy Building on and enhancing DOTS to meet teh TB-related Millennium Development Goals. Geneva: World Health Organization. Available at: https://www.who.int/tb/strategy/stop_tb_strategy/en/.
World Health Organization (2014) Teh End TB Strategy- Global strategy and targets for tuberculosis prevention, care and control after 2015. Geneva: World Health Organization.
World Health Organization (2018) Global Tuberculosis Report 2018. Geneva.
World Health Organization (2019) WHO Guidelines On Tuberculosis Infection Prevention and Control- Teh End TB Strategy. Geneva: World Health Organization.
Yoisangadji, A. S., Maramis, F. R. R. and Rumayar, A. A. (2016) ‘Hubungan Antara Pengawas Menelan Obat (PMO) dan Peran Keluarga dengan Kepatuhan Minum Obat pada Pasien Tuberkulosis di Wilayah Kerja Puskesmas Sario Kota Manado', PHARMACON Jurnal Ilmiah Farmasi, 5(2), pp. 138–143.
1. As an author you (or your employer or institution) may do the following:
- make copies (print or electronic) of the article for your own personal use, including for your own classroom teaching use;
- make copies and distribute such copies (including through e-mail) of the article to research colleagues, for the personal use by such colleagues (but not commercially or systematically, e.g. via an e-mail list or list server);
- present the article at a meeting or conference and to distribute copies of the article to the delegates attending such meeting;
- for your employer, if the article is a ‘work for hire', made within the scope of your employment, your employer may use all or part of the information in the article for other intra-company use (e.g. training);
- retain patent and trademark rights and rights to any process, procedure, or article of manufacture described in the article;
- include the article in full or in part in a thesis or dissertation (provided that this is not to be published commercially);
- use the article or any part thereof in a printed compilation of your works, such as collected writings or lecture notes (subsequent to publication of the article in the journal); and prepare other derivative works, to extend the article into book-length form, or to otherwise re-use portions or excerpts in other works, with full acknowledgement of its original publication in the journal;
- may reproduce or authorize others to reproduce the article, material extracted from the article, or derivative works for the author's personal use or for company use, provided that the source and the copyright notice are indicated.
All copies, print or electronic, or other use of the paper or article must include the appropriate bibliographic citation for the article's publication in the journal.
2. Requests from third parties
Although authors are permitted to re-use all or portions of the article in other works, this does not include granting third-party requests for reprinting, republishing, or other types of re-use.
3. Author Online Use
- Personal Servers. Authors and/or their employers shall have the right to post the accepted version of articles pre-print version of the article, or revised personal version of the final text of the article (to reflect changes made in the peer review and editing process) on their own personal servers or the servers of their institutions or employers without permission from JAKI;
- Classroom or Internal Training Use. An author is expressly permitted to post any portion of the accepted version of his/her own articles on the author's personal web site or the servers of the author's institution or company in connection with the author's teaching, training, or work responsibilities, provided that the appropriate copyright, credit, and reuse notices appear prominently with the posted material. Examples of permitted uses are lecture materials, course packs, e-reserves, conference presentations, or in-house training courses;
